Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity

EJJ. Kallen, A. Revers, M. Fernández-Rivas, R. Asero, B. Ballmer-Weber, L. Barreales, S. Belohlavkova, F. de Blay, M. Clausen, R. Dubakiene, M. Ebisawa, C. Fernández-Perez, P. Fritsche, Y. Fukutomi, D. Gislason, K. Hoffmann-Sommergruber, M....

. 2023 ; 78 (9) : 2497-2509. [pub] 20230619

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016406

BACKGROUND: Pru p 3 and Pru p 7 have been implicated as risk factors for severe peach allergy. This study aimed to establish sensitization patterns to five peach components across Europe and in Japan, to explore their relation to pollen and foods and to predict symptom severity. METHODS: In twelve European (EuroPrevall project) and one Japanese outpatient clinic, a standardized clinical evaluation was conducted in 1231 patients who reported symptoms to peach and/or were sensitized to peach. Specific IgE against Pru p 1, 2, 3, 4 and 7 and against Cup s 7 was measured in 474 of them. Univariable and multivariable Lasso regression was applied to identify combinations of parameters predicting severity. RESULTS: Sensitization to Pru p 3 dominated in Southern Europe but was also quite common in Northern and Central Europe. Sensitization to Pru p 7 was low and variable in the European centers but very dominant in Japan. Severity could be predicted by a model combining age of onset of peach allergy, probable mugwort, Parietaria pollen and latex allergy, and sensitization to Japanese cedar pollen, Pru p 4 and Pru p 7 which resulted in an AUC of 0.73 (95% CI 0.73-0.74). Pru p 3 tended to be a risk factor in South Europe only. CONCLUSIONS: Pru p 7 was confirmed as a significant risk factor for severe peach allergy in Europe and Japan. Combining outcomes from clinical and demographic background with serology resulted in a model that could better predict severity than CRD alone.

Allergist and Pediatrician Nápoles y Sicilia Health Center Valencia Spain

Allergy Department 2nd Pediatric Clinic University of Athens Athens Greece

Allergy Division Chest Disease Department Strasbourg University Hospital Strasbourg France

Allergy Unit Department of Dermatology University Hospital of Zürich Zürich Switzerland

Ambulatorio di Allergologia Clinica San Carlo Paderno Dugnano Italy

Clinic for Dermatology and Allergology Kantonsspital St Gallen St Gallen Switzerland

Clinic of Chest diseases Allergology and Immunology Institute of Clinic al Medicine Medical Faculty Vilnius University Vilnius Lithuania

Clinic of Occupational Diseases University Hospital Sv Ivan Rilski Sofia Bulgaria

Clinical Research Center for Allergy and Rheumatology National Hospital Organization Sagamihara National Hospital Kanagawa Japan

Department of Allergy Hospital Clinico San Carlos Universidad Complutense IdISSC ARADyAL Madrid Spain

Department of Dermatology Allergology University Medical Center Utrecht Utrecht University Utrecht The Netherlands

Department of Experimental Immunology Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

Department of Immunology and Allergy Faculty of Medicine Medical University of Lodz Lodz Poland

Department of Nutritional Sciences and Dietetics International Hellenic University Thessaloniki Greece

Department of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria

Departments of Experimental Immunology and of Otorhinolaryngology Amsterdam University Medical Center Amsterdam The Netherlands

Division of Infection Immunity and Respiratory Medicine Manchester Institute of Biotechnology and Lydia Becker Institute of Immunology and Inflammation University of Manchester Manchester UK

Epidemiology and Data Science Amsterdam University Medical Center location University of Amsterdam Amsterdam The Netherlands

Faculty of Medicine University of Zürich Zürich Switzerland

Institute of Immunity and Transplantation University College London London UK

Landspitali University Hospital University of Iceland Faculty of Medicine Reykjavik Iceland

Medical Faculty Pilsen Charles University Prague Prague Czech Republic

Paul Ehrlich Institut Federal Institute for Vaccines and Biomedicines Langen Germany

Servicio de Medicina Preventiva Area De Santiago de Compostela y Barbanza Instituto de Investigación Sanitaria de Santiago A Coruña Santiago Spain

Thermo Fisher Scientific Uppsala Sweden

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016406
003      
CZ-PrNML
005      
20231026105909.0
007      
ta
008      
231013s2023 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/all.15783 $2 doi
035    __
$a (PubMed)37334557
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Kallen, E J J $u Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands $1 https://orcid.org/0000000157115552
245    12
$a A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity / $c EJJ. Kallen, A. Revers, M. Fernández-Rivas, R. Asero, B. Ballmer-Weber, L. Barreales, S. Belohlavkova, F. de Blay, M. Clausen, R. Dubakiene, M. Ebisawa, C. Fernández-Perez, P. Fritsche, Y. Fukutomi, D. Gislason, K. Hoffmann-Sommergruber, M. Jedrzejczak-Czechowicz, AC. Knulst, ML. Kowalski, T. Kralimarkova, J. Lidholm, C. Metzler, ENC. Mills, NG. Papadopoulos, TA. Popov, A. Purohit, I. Reig, SL. Seneviratne, A. Sinaniotis, M. Takei, SA. Versteeg, AE. Vassilopoulou, S. Vieths, PMJ. Welsing, AH. Zwinderman, TM. Le, R. Van Ree
520    9_
$a BACKGROUND: Pru p 3 and Pru p 7 have been implicated as risk factors for severe peach allergy. This study aimed to establish sensitization patterns to five peach components across Europe and in Japan, to explore their relation to pollen and foods and to predict symptom severity. METHODS: In twelve European (EuroPrevall project) and one Japanese outpatient clinic, a standardized clinical evaluation was conducted in 1231 patients who reported symptoms to peach and/or were sensitized to peach. Specific IgE against Pru p 1, 2, 3, 4 and 7 and against Cup s 7 was measured in 474 of them. Univariable and multivariable Lasso regression was applied to identify combinations of parameters predicting severity. RESULTS: Sensitization to Pru p 3 dominated in Southern Europe but was also quite common in Northern and Central Europe. Sensitization to Pru p 7 was low and variable in the European centers but very dominant in Japan. Severity could be predicted by a model combining age of onset of peach allergy, probable mugwort, Parietaria pollen and latex allergy, and sensitization to Japanese cedar pollen, Pru p 4 and Pru p 7 which resulted in an AUC of 0.73 (95% CI 0.73-0.74). Pru p 3 tended to be a risk factor in South Europe only. CONCLUSIONS: Pru p 7 was confirmed as a significant risk factor for severe peach allergy in Europe and Japan. Combining outcomes from clinical and demographic background with serology resulted in a model that could better predict severity than CRD alone.
650    _2
$a lidé $7 D006801
650    12
$a Prunus persica $x škodlivé účinky $7 D000068239
650    12
$a potravinová alergie $x diagnóza $7 D005512
650    _2
$a alergeny $7 D000485
650    _2
$a antigeny rostlinné $7 D052179
650    _2
$a imunoglobulin E $7 D007073
650    _2
$a rostlinné proteiny $7 D010940
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Revers, A $u Epidemiology and Data Science (EDS), Amsterdam University Medical Center location University of Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/0000000262957153
700    1_
$a Fernández-Rivas, M $u Department of Allergy, Hospital Clinico San Carlos, Universidad Complutense, IdISSC, ARADyAL, Madrid, Spain
700    1_
$a Asero, R $u Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy $1 https://orcid.org/0000000282771700
700    1_
$a Ballmer-Weber, B $u Allergy Unit, Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland $u Faculty of Medicine, University of Zürich, Zürich, Switzerland $u Clinic for Dermatology and Allergology, Kantonsspital St. Gallen, St. Gallen, Switzerland
700    1_
$a Barreales, L $u Department of Allergy, Hospital Clinico San Carlos, Universidad Complutense, IdISSC, ARADyAL, Madrid, Spain
700    1_
$a Belohlavkova, S $u Medical Faculty Pilsen, Charles University Prague, Prague, Czech Republic
700    1_
$a de Blay, F $u Allergy Division, Chest Disease Department, Strasbourg University Hospital, Strasbourg, France
700    1_
$a Clausen, M $u Landspitali University Hospital, University of Iceland, Faculty of Medicine, Reykjavik, Iceland
700    1_
$a Dubakiene, R $u Clinic of Chest diseases, Allergology and Immunology Institute of Clinic al Medicine Medical Faculty Vilnius University, Vilnius, Lithuania
700    1_
$a Ebisawa, M $u Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan $1 https://orcid.org/000000034117558X
700    1_
$a Fernández-Perez, C $u Servicio de Medicina Preventiva, Area De Santiago de Compostela y Barbanza, Instituto de Investigación Sanitaria de Santiago (IDIS) A Coruña, Santiago, Spain
700    1_
$a Fritsche, P $u Allergy Unit, Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland
700    1_
$a Fukutomi, Y $u Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan $1 https://orcid.org/0000000199134524
700    1_
$a Gislason, D $u Landspitali University Hospital, University of Iceland, Faculty of Medicine, Reykjavik, Iceland
700    1_
$a Hoffmann-Sommergruber, K $u Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
700    1_
$a Jedrzejczak-Czechowicz, M $u Department of Immunology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland
700    1_
$a Knulst, A C $u Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands $1 https://orcid.org/0000000210563179
700    1_
$a Kowalski, M L $u Department of Immunology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland
700    1_
$a Kralimarkova, T $u Clinic of Occupational Diseases, University Hospital Sv. Ivan Rilski, Sofia, Bulgaria
700    1_
$a Lidholm, J $u Thermo Fisher Scientific, Uppsala, Sweden $1 https://orcid.org/0000000277793411
700    1_
$a Metzler, C $u Allergy Unit, Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland
700    1_
$a Mills, E N C $u Division of Infection, Immunity and Respiratory Medicine, Manchester Institute of Biotechnology & Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK
700    1_
$a Papadopoulos, N G $u Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece
700    1_
$a Popov, T A $u Clinic of Occupational Diseases, University Hospital Sv. Ivan Rilski, Sofia, Bulgaria
700    1_
$a Purohit, A $u Allergy Division, Chest Disease Department, Strasbourg University Hospital, Strasbourg, France
700    1_
$a Reig, I $u Allergist and Pediatrician, Nápoles y Sicilia Health Center, Valencia, Spain
700    1_
$a Seneviratne, S L $u Institute of Immunity and Transplantation, University College London, London, UK
700    1_
$a Sinaniotis, A $u Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece
700    1_
$a Takei, M $u Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan
700    1_
$a Versteeg, S A $u Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Vassilopoulou, A E $u Department of Nutritional Sciences and Dietetics, International Hellenic University, Thessaloniki, Greece
700    1_
$a Vieths, S $u Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany
700    1_
$a Welsing, P M J $u Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands $1 https://orcid.org/0000000323612803
700    1_
$a Zwinderman, A H $u Epidemiology and Data Science (EDS), Amsterdam University Medical Center location University of Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/0000000303613139 $7 ctu2013760061
700    1_
$a Le, T M $u Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands $1 https://orcid.org/000000016571220X
700    1_
$a Van Ree, R $u Departments of Experimental Immunology and of Otorhinolaryngology, Amsterdam University Medical Center, Amsterdam, The Netherlands $1 https://orcid.org/0000000307670894
773    0_
$w MED00009088 $t Allergy $x 1398-9995 $g Roč. 78, č. 9 (2023), s. 2497-2509
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37334557 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105903 $b ABA008
999    __
$a ok $b bmc $g 2000117 $s 1202768
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 78 $c 9 $d 2497-2509 $e 20230619 $i 1398-9995 $m Allergy $n Allergy $x MED00009088
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace